Clinical Trials Directory

Trials / Unknown

UnknownNCT01952275

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Assessment of the Enrichment of Rare Coding Genetic Variants in Patients Affected by Neutrophil-Mediated Inflammatory Dermatoses

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
120 Years
Healthy volunteers
Not accepted

Summary

This study investigates the genetic architecture of Neutrophil-Mediated Inflammatory Skin Diseases. After collecting informed consent, all patients' clinical phenotype is graded at inclusion with a detailed case report form and a discovery cohort formed based on the certainty of diagnosis. The DNA of patients in the discovery cohort is analyzed by whole exome sequencing which identifies all protein-coding genetic variants. Subsequently, statistical burden tests are going to identify enrichment of rare coding genetic variants in patients affected by Neutrophil-Mediated Inflammatory Skin Diseases. The ultimate goal is to reveal the responsible gene(s) that may then be targets for clinical intervention.

Detailed description

Timeframe: * Collection of DNA for discovery cohort until 05/2016 * Data analysis until 12/2014 for pyoderma gangrenosum, until 12/2016 for other NMID * Report and data presentation early 2015 for PG, 2017 for other NMID

Conditions

Interventions

TypeNameDescription
PROCEDURECollection of biological samples

Timeline

Start date
2014-01-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2013-09-27
Last updated
2016-09-27

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01952275. Inclusion in this directory is not an endorsement.